Patents by Inventor Marc Young

Marc Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250339516
    Abstract: The invention pertains to methods and means for the targeted modulation of B-cell mediated immune responses by bringing into contact a B-cell with a specific ratio of soluble single monovalent antigens and complexed multivalent antigens. The targeted modulation of B-cell immunity can be used in mammals for the diagnosis and therapy of various conditions associated with antibody-mediated immunity. Such conditions include proliferative disorders such as cancer, autoimmune disorders, pathogenic infections, inflammatory diseases, allergies and food intolerances. The invention is predicated on the observation that complexed multivalent antigenic structures induce a strong IgG type antibody B-cell response while surprisingly monovalent antigenic structures harbour the ability to suppress such IgG responses, or even induce in the case of autoantigens protective IgM responses. The invention in this regard offers methods, compositions, therapeutics, diagnostics and food additives.
    Type: Application
    Filed: January 28, 2022
    Publication date: November 6, 2025
    Inventors: Hassan JUMAA-WEINACHT, Timm AMENDT, Marc YOUNG
  • Publication number: 20250270311
    Abstract: The invention pertains to methods and means for the targeted modulation of B-cell mediated immune responses by bringing into contact a B-cell with a specific ratio of soluble single monovalent antigens and complexed multivalent antigens. The targeted modulation of B-cell immunity can be used in mammals for the diagnosis and therapy of various conditions associated with antibody-mediated immunity. Such conditions include proliferative disorders such as cancer, autoimmune disorders, pathogenic infections, inflammatory diseases, allergies and food intolerances. The invention is predicated on the observation that complexed multivalent antigenic structures induce a strong IgG type antibody B-cell response while surprisingly monovalent antigenic structures harbour the ability to suppress such IgG responses, or even induce in the case of autoantigens protective IgM responses, in particular protective oligomeric anti-insulin antibodies.
    Type: Application
    Filed: January 28, 2022
    Publication date: August 28, 2025
    Inventors: Hassan JUMAA-WEINACHT, Timm AMENDT, Marc YOUNG
  • Patent number: 8635539
    Abstract: Suggested edits to translated text are enabled to be provided by users. The suggested edits are associated with the translated text in a content database. A subsequent user may view the translated text and any associated suggested edits. The subsequent user may be enabled to approve a suggested edit to the translated text. The translated text is enabled to be displayed as modified according to the approved suggested edit. This may include enabling multiple instances of the translated text to be displayed as modified according to the suggested edit if the translated text occurs multiple times (e.g., appears multiple times in one or more documents) in the content database. Further users that attempt to view the translated text in a document of the content database will be provided with the modified version of the translated text.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: January 21, 2014
    Assignee: Microsoft Corporation
    Inventors: Marc Young, Molly Bostic, John Mollman
  • Publication number: 20100115424
    Abstract: Suggested edits to translated text are enabled to be provided by users. The suggested edits are associated with the translated text in a content database. A subsequent user may view the translated text and any associated suggested edits. The subsequent user may be enabled to approve a suggested edit to the translated text. The translated text is enabled to be displayed as modified according to the approved suggested edit. This may include enabling multiple instances of the translated text to be displayed as modified according to the suggested edit if the translated text occurs multiple times (e.g., appears multiple times in one or more documents) in the content database. Further users that attempt to view the translated text in a document of the content database will be provided with the modified version of the translated text.
    Type: Application
    Filed: October 31, 2008
    Publication date: May 6, 2010
    Applicant: Microsoft Corporation
    Inventors: Marc Young, Molly Bostic, John Mollman